Physician

Allergy & Immunology

Dr. Deborah L. Birx, MD

Doctor Deborah L. Birx, MD practices Allergy & Immunology. Dr. Deborah L. Birx is also published. He has 59 publications published. The lastest publication: "Safety and Immunogenicity of a randomized Phase I prime-boost trial with ALVAC-HIV (vCP205) and Oligomeric gp160 MN/LAI-2 Adjuvanted in Alum or Polyphosphazene.'

Publications

Safety and Immunogenicity of a randomized Phase I prime-boost trial with ALVAC-HIV (vCP205) and Oligomeric gp160 MN/LAI-2 Adjuvanted in Alum or Polyphosphazene.
"Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial"
Improving African lab medicine.
Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania.
Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.
The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region.
HIV-1 incidence rates and risk factors in agricultural workers and dependents in rural Kenya: 36-month follow-up of the Kericho HIV cohort study.
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya.
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.
Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya.
Exposure to wild primates among HIV-infected persons.
Genetic characterization of HIV-1 strains circulating in Kazakhstan.
The protective effect of circumcision on HIV incidence in rural low-risk men circumcised predominantly by traditional circumcisers in Kenya: two-year follow-up of the ...
Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand.
Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.
Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.
HIV incidence trends among white and african-american active duty United States Army personnel (1986-2003).
Epidemiology of HIV-1 infection in agricultural plantation residents in Kericho, Kenya: preparation for vaccine feasibility studies.
Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.
Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping.
Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.
Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania.
Trends in HIV prevalence among white and African-American civilian applicants for United States Military Service, 1985 to 2003.
Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.
Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan.
Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the de...
Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel.
Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians.
Exposure to nonhuman primates in rural Cameroon.
Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.
HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321.
HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania.
Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.
HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians.
The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002.
Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa.
Policy rebuttal. HIV vaccine trial justified.
A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions.
Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype ...
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand.
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.
Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
HIV-1 infection among civilian applicants for US military service, 1985 to 2000: epidemiology and geography.
HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest.
Comparison between env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and H...
Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate.
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells.
Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand.
HIV type 1 strains from East and West Africa are intermixed in Sudan.
Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa.
Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo.
Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0...
Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

Schools

Pennsylvania State University College of Medicine
Walter Reed Army Med Center

Doctors Specialties

Allergy
Immunology

Accepted Insurances

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Marissa R. Shams, MD This Doctor is OpenDoctor Recommended.
	Dr. Keith M. Phillips, MD This Doctor is OpenDoctor Recommended.
	Dr. Luqman Seidu, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer A. Shih, MD This Doctor is OpenDoctor Recommended.
	Umbreen S. Lodi, MB This Doctor is OpenDoctor Recommended.